SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

VEERHEALTH CARE

BSE: 511523 29 Jun 2025
Healthcare
₹ 17.3
Veerhealth Care Limited specializes in Pharmaceuticals within the Healthcare sector.

VEERHEALTH CARE - Share Price & Details

Market Cap
₹35.9
High /Low
27.0 / 9.29
Stock P/E
92.1
Book Value
₹11.1
Dividend Yield
0.0
ROCE
3.14
ROE
₹1.77
Face Value
10.0
PEG Ratio
22.8
EVEBITDA
₹23.6
Debt
4.91
CMP / FCF
-11.0
Debt to equity
₹0.22
NP Ann
0.39
High price all time
30.1
Piotroski score
₹2.0
Graham Number
6.98
No. Eq. Shares
2.0
Net CF
₹0.92
Net profit
0.39
Price to book value
1.62
Interest Coverage
₹2.96
Low price all time
0.9
Industry PE
32.0
Reserves
₹2.22
Free Cash Flow
₹-9.20

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
VEERHEALTH CARE LIMITEDNANANANA35.992.1
Concord Drugs LimitedNANANANA34.5101.0
Shree Ganesh Biotech (India) LNANANANA34.3122.0

Peer Comparison Chart


About VEERHEALTH CARE

Veerhealth Care Limited, with Security Code 511523, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Vivimed Labs Share Price

(21 Jun 2025)
Vivimed Labs Limited was originally incorporated on September 22 1988 as a private limited company in the name of Emgi Pharmaceuticals & Chemicals Pvt Ltd.
Read more →

Veerhealth Care Standalone March 2025 Net Sales at Rs 5.62 crore, up 66.9% Y-o-Y

(13 Jun 2025)
Net Sales at Rs 5.62 crore in March 2025 up 66.9% from Rs. 3.37 crore in March 2024. Story continues below Advertisement.
Read more →

Who are in the management team of Veerhealth Care?

(07 Jun 2025)
As of March 2022, the management team of Veerhealth Care includes Shruti Y Shah (Executive Director), Bhavin S Shah (Managing Director),...
Read more →

Veerhealth Care Reports Mixed Financial Results Amid Strong Sales Growth in March 2025

(01 Jun 2025)
Veerhealth Care has announced its financial results for the quarter ending March 2025, showing a significant year-on-year growth in net sales of 51.60%,...
Read more →

Veerhealth Care Ltd Sees Strong Buying Activity Amid Market Outperformance

(28 May 2025)
Veerhealth Care Ltd Sees Strong Buying Activity Amid Market Outperformance ... Veerhealth Care Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, is...
Read more →

Veerhealth Care Limited Reports Successful Closure of Inspection by USFDA under 21 CFR 20.64(d) (3) exemplifying the saying "Chota packet bada dhamaka"

(21 May 2025)
Veerhealth Care Limited announced that USFDA has concluded that their inspection is closed under 21 CFR 20.64. With the above audit closure...
Read more →